NCT05541406 Efficacy of a Multi-level School Intervention for LGBTQ Youth
| NCT ID | NCT05541406 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington University School of Medicine |
| Condition | Depression |
| Study Type | INTERVENTIONAL |
| Enrollment | 228 participants |
| Start Date | 2022-09-14 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 228 participants in total. It began in 2022-09-14 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Efficacy of a Multi-level School Intervention for LGBTQ Youth
Eligibility Criteria
Inclusion Criteria: * LGBTQ student in one of 24 high schools Exclusion Criteria: * Not meeting inclusion criteria
Contact & Investigator
Harmony Rhoades, PhD
PRINCIPAL INVESTIGATOR
Washington University School of Medicine
Frequently Asked Questions
Who can join the NCT05541406 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 20 Years, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05541406 currently recruiting?
Yes, NCT05541406 is actively recruiting participants. Contact the research team at b.lumsdaine@wustl.edu for enrollment information.
Where is the NCT05541406 trial being conducted?
This trial is being conducted at El Monte, United States, El Monte, United States, El Monte, United States, El Monte, United States and 11 additional locations.
Who is sponsoring the NCT05541406 clinical trial?
NCT05541406 is sponsored by Washington University School of Medicine. The principal investigator is Harmony Rhoades, PhD at Washington University School of Medicine. The trial plans to enroll 228 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.